HbA1c and lower extremity amputation risk in patients with diabetes: A meta-analysis

International Journal of Lower Extremity Wounds

Volumn 14, Issue 2, 2015, Pages 168-177

  Zhou, Zhen Yu ^a,b   Liu, Ya Ke ^b   Chen, Hong Lin ^b   Yang, Hui Lin ^a   Liu, Fan ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

diabetes mellitus; glycosylated hemoglobin; lower extremity amputation; meta analysis; risk factor

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; CONFIDENCE INTERVAL; DIABETES MELLITUS; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LEG AMPUTATION; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; AMPUTATION; BLOOD; DIABETIC FOOT; LOWER LIMB; METABOLISM;

AMPUTATION; DIABETIC FOOT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOWER EXTREMITY; RISK FACTORS;

EID: 84937562882     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734615593190     Document Type: Article

References (35)

1. Singh N, Armstrong DG, Lipsky BA,. Preventing foot ulcers in patients with diabetes. JAMA. 2005; 293: 217-228.
2. Moxey PW, Gogalniceanu P, Hinchliffe RJ,. Lower extremity amputations-a review of global variability in incidence. Diabet Med. 2011; 28: 1144-1153.
3. Yin H, Radican L, Kong SX,. A study of regional variation in the inpatient cost of lower extremity amputation among patients with diabetes in the United States. J Med Econ. 2013; 16: 820-827.
4. Hoffmann F, Claessen H, Morbach S, Waldeyer R, Glaeske G, Icks A,. Impact of diabetes on costs before and after major lower extremity amputations in Germany. J Diabetes Complications. 2013; 27: 467-472.
5. Pscherer S, Dippel FW, Lauterbach S, Kostev K,. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes. 2012; 6: 241-246.
6. Yang Y, Østbye T, Tan SB, Abdul Salam ZH, Ong BC, Yang KS,. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complications. 2011; 25: 382-386.
7. Rai NK, Suryabhan, Ansari M, Kumar M, Shukla VK, Tripathi K,. Effect of glycaemic control on apoptosis in diabetic wounds. J Wound Care. 2005; 14: 277-281.
8. Imran S, Ali R, Mahboob G,. Frequency of lower extremity amputation in diabetics with reference to glycemic control and Wagner's grades. J Coll Physicians Surg Pak. 2006; 16: 124-127.
9. Kowall B, Rathmann W,. HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? Diabetes Metab Syndr Obes. 2013; 6: 477-491.
10. Wells GA, Shea B, O'Connell D,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed December 12, 2014.
11. Greenland S, Longnecker MP,. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992; 135: 1301-1309.
12. Orsini N, Bellocco R, Greenland S,. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006; 6: 40-57.
13. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D,. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012; 175: 66-73.
14. Tabur S, Eren MA, Celik Y,. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr. 2015; 127: 45-50.
15. Zhao W, Katzmarzyk PT, Horswell R,. HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care. 2013; 36: 3591-3598.
16. Laclé A, Valero-Juan LF,. Diabetes-related lower-extremity amputation incidence and risk factors: a prospective seven-year study in Costa Rica. Rev Panam Salud Publica. 2012; 32: 192-198.
17. Fei YF, Wang C, Chen DW,. Incidence and risk factors of amputation among inpatients with diabetic foot. Zhonghua Yi Xue Za Zhi. 2012; 92: 1686-1689.
18. Zubair M, Malik A, Ahmad J,. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. Foot (Edinb). 2012; 22: 24-30.
19. Li X, Xiao T, Wang Y,. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011; 93: 26-30.
20. Callaghan BC, Feldman E, Liu J,. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care. 2011; 34: 635-640.
21. Davis WA, Norman PE, Bruce DG, Davis TM,. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia. 2006; 49: 2634-2641.
22. Olson JC, Erbey JR, Forrest KY, Williams K, Becker DJ, Orchard TJ,. Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. Metabolism. 2002; 51: 248-254.
23. Watts SA, Daly B, Anthony M, McDonald P, Khoury A, Dahar W,. The effect of age, gender, risk level and glycosylated hemoglobin in predicting foot amputation in HMO patients with diabetes. J Am Acad Nurse Pract. 2001; 13: 230-235.
24. Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M,. Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy. Diabet Med. 2000; 17: 727-734.
25. Stratton IM, Adler AI, Neil HA,. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321: 405-412.
26. Adler AI, Boyko EJ, Ahroni JH, Smith DG,. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999; 22: 1029-1035.
27. Moss SE, Klein R, Klein BE,. The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care. 1999; 22: 951-959.
28. Coppini DV, Young PJ, Weng C, Macleod AF, Sönksen PH,. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet Med. 1998; 15: 765-771.
29. Lehto S, Rönnemaa T, Pyörälä K, Laakso M,. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care. 1996; 19: 607-612.
30. Jbour AS, Jarrah NS, Radaideh AM,. Prevalence and predictors of diabetic foot syndrome in type 2 diabetes mellitus in Jordan. Saudi Med J. 2003; 24: 761-764.
31. Loprinzi PD, Hager KK, Ramulu PY,. Physical activity, glycemic control, and diabetic peripheral neuropathy: a national sample. J Diabetes Complications. 2014; 28: 17-21.
32. Pop-Busui R, Lu J, Brooks MM, BARI 2D Study Group. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) cohort. Diabetes Care. 2013; 36: 3208-3215.
33. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR,. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2006; 29: 877-882.
34. Brechow A, Slesaczeck T, Münch D,. Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease. Ther Adv Endocrinol Metab. 2013; 4 (3): 83-94.
35. Monteiro-Soares M, Martins-Mendes D, Vaz-Carneiro A, Sampaio S, Dinis-Ribeiro M,. Classification systems for lower extremity amputation prediction in subjects with active diabetic foot ulcer: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2014; 30: 610-622.